A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke

European Journal of Neurology

Volumn 8, Issue 6, 2001, Pages 559-565

  Bakheit, A M O ^a   Pittock, S ^b   Moore, A P ^c   Wurker, M ^d   Otto, S ^e   Erbguth, F ^f   Coxon, L ^g  

^a Mount Gould Hospital   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

^c Clinical Trials Unit   (United Kingdom)

^d Neurol Reha Klinik Godeshohe eV   (Germany)

^e ST JOSEF HOSPITAL   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g IPSEN   (France)

Author keywords

Botulinum toxin; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ACCIDENT; ADULT; AGED; ARM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELBOW; FEMALE; FOLLOW UP; HUMAN; INJURY; MALE; MULTICENTER STUDY; MUSCLE TONE; MYALGIA; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SPASTICITY; STATISTICAL SIGNIFICANCE; STROKE; TIME; URINARY TRACT INFECTION;

AGED; ARM; BOTULINUM TOXIN TYPE A; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 0035553935     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2001.00277.x     Document Type: Article

References (19)

1. Cerebrovascular disease in the community: Results of a WHO collaborative study
2. The effectiveness of chemical neurolysis in the treatment of lower limb muscle spasticity
3. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
4. Use of botulinum toxin in stroke patients with severe upper limb spasticity
5. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial
6. Inter-rater reliability of a modified Ashworth Scale of muscle spasticity
7. The Barthel ADL Index: Reliability study
8. Effect of treatment with botulinum toxin on spasticity
9. Management of hemiplegic upper limb
10. Botulinum toxin therapy for upper limb flexor spasticity: Preliminary results
11. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomised, double blind, placebo-controlled trial
12. Botulinum toxin injections for cervical dystonia
13. Objective assessment of spasticity, strength and function with early exhibition of dantrolene sodium after cerebrovascular accident: A randomised, double-blind study
14. Impairment of voluntary movement by spasticity
15. Botulinum toxin type A in the treatment of upper limb extremity spasticity: A randomised, double-blind, placebo-controlled trial
16. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury
17. The clinical usefulness of botulinum toxin A in treating neurologic disorders
18. Recovery after stroke: The first three months